Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma
CONCLUSION: Our findings demonstrate that SOAT1 may serve as a novel target for HCC treatment, which is helpful for the development of new strategies for immunotherapy and metabolic therapy.PMID:38577529 | PMC:PMC10989313 | DOI:10.4254/wjh.v16.i3.439
Source: World Journal of Hepatology - Category: Gastroenterology Authors: Chang-Jiao Gan Yue Zheng Bin Yang Li-Min Cao Source Type: research
More News: Calcium | Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Genetics | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Urology & Nephrology